Resistance to BRAF Inhibition in Melanomas

被引：188
|
作者：
Solit, David B. [1 ]
Rosen, Neal [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 08期
关键词：
RAF; PATHWAY; CRAF;
D O I：
10.1056/NEJMcibr1013704
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：772 / 774
页数：3
相关论文
共 50 条
  • [31] Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors
    Levy, Jean M. Mulcahy
    Zahedi, Shadi
    Griesinger, Andrea M.
    Morin, Andrew
    Davies, Kurtis D.
    Aisner, Dara L.
    Kleinschmidt-DeMasters, B. K.
    Fitzwalter, Brent E.
    Goodall, Megan L.
    Thorburn, Jacqueline
    Amani, Vladimir
    Donson, Andrew M.
    Birks, Diane K.
    Mirsky, David M.
    Hankinson, Todd C.
    Handler, Michael H.
    Green, Adam L.
    Vibhakar, Rajeev
    Foreman, Nicholas K.
    Thorburn, Andrew
    [J]. ELIFE, 2017, 6
  • [32] Many Distinct Ways Lead to Drug Resistance in BRAF- and NRAS-Mutated Melanomas
    Vachtenheim, Jiri
    Ondrusova, Lubica
    [J]. LIFE-BASEL, 2021, 11 (05):
  • [33] Inhibition of HSP90 by AT13387 Delays the Emergence of Resistance to BRAF Inhibitors and Overcomes Resistance to Dual BRAF and MEK Inhibition in Melanoma Models
    Smyth, Tomoko
    Paraiso, Kim H. T.
    Hearn, Keisha
    Rodriguez-Lopez, Ana M.
    Munck, Joanne M.
    Haarberg, H. Eirik
    Sondak, Vernon K.
    Thompson, Neil T.
    Azab, Mohammad
    Lyons, John F.
    Smalley, Keiran S. M.
    Wallis, Nicola G.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2793 - 2804
  • [34] PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
    Lu, Hezhe
    Liu, Shujing
    Zhang, Gao
    Wu, Bin
    Zhu, Yueyao
    Frederick, Dennie T.
    Hu, Yi
    Zhong, Wenqun
    Randell, Sergio
    Sadek, Norah
    Zhang, Wei
    Chen, Gang
    Cheng, Chaoran
    Zeng, Jingwen
    Wu, Lawrence W.
    Zhang, Jie
    Liu, Xiaoming
    Xu, Wei
    Krepler, Clemens
    Sproesser, Katrin
    Xiao, Min
    Miao, Benchun
    Liu, Jianglan
    Song, Claire D.
    Liu, Jephrey Y.
    Karakousis, Giorgos C.
    Schuchter, Lynn M.
    Lu, Yiling
    Mills, Gordon
    Cong, Yusheng
    Chernoff, Jonathan
    Guo, Jun
    Boland, Genevieve M.
    Sullivan, Ryan J.
    Wei, Zhi
    Field, Jeffrey
    Amaravadi, Ravi K.
    Flaherty, Keith T.
    Herlyn, Meenhard
    Xu, Xiaowei
    Guo, Wei
    [J]. NATURE, 2017, 550 (7674) : 133 - +
  • [35] PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
    Hezhe Lu
    Shujing Liu
    Gao Zhang
    Yueyao Bin Wu
    Dennie T. Zhu
    Yi Frederick
    Wenqun Hu
    Sergio Zhong
    Norah Randell
    Wei Sadek
    Gang Zhang
    Chaoran Chen
    Jingwen Cheng
    Lawrence W. Zeng
    Jie Wu
    Xiaoming Zhang
    Wei Liu
    Clemens Xu
    Katrin Krepler
    Min Sproesser
    Benchun Xiao
    Jianglan Miao
    Claire D. Liu
    Jephrey Y. Song
    Giorgos C. Liu
    Lynn M. Karakousis
    Yiling Schuchter
    Gordon Lu
    Yusheng Mills
    Jonathan Cong
    Jun Chernoff
    Genevieve M. Guo
    Ryan J. Boland
    Zhi Sullivan
    Jeffrey Wei
    Ravi K. Field
    Keith T. Amaravadi
    Meenhard Flaherty
    Xiaowei Herlyn
    Wei Xu
    [J]. Nature, 2017, 550 : 133 - 136
  • [36] BRAF and NRAS Mutation Status of primary Melanomas of Patients with Second and Multiple Melanomas
    Schmitt, A.
    Bauer, J.
    Meiss, F.
    Nashan, D.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 11 - 11
  • [37] Variations of BRAF mutant allele percentage in melanomas
    Helias-Rodzewicz, Zofia
    Funck-Brentano, Elisa
    Baudoux, Laure
    Jung, Chan Kwon
    Zimmermann, Ute
    Marin, Cristi
    Clerici, Thierry
    Le Gall, Catherine
    Peschaud, Frererique
    Taly, Valerie
    Saiag, Philippe
    Emile, Jean-Franois
    [J]. BMC CANCER, 2015, 15
  • [38] Rapid BRAF Mutation Testing in Pigmented Melanomas
    Petty, Danielle R.
    Hassan, Omer A.
    Barker, Callie S.
    O'Neill, Stacey S.
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2020, 42 (05) : 343 - 348
  • [39] PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN
    Qin, Yifei
    Zuo, Qiang
    Huang, Lei
    Huang, Liping
    Merlino, Glenn
    Yu, Yanlin
    [J]. NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [40] Autophagy inhibition reverses resistance to targeted BRAF therapy in CNS
    Zahedi, Shadi
    Griesinger, Andrea M.
    Hankinson, Todd C.
    Handler, Michael H.
    Foreman, Nicholas K.
    Thorburn, Andrew
    Levy, Jean M. Mulcahy
    [J]. CANCER RESEARCH, 2015, 75
12345